Lianhong Xu, PhD

Brii Biosciences
San Mateo, North Carolina, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 2252 - Safety, Tolerability, and Pharmacokinetics of BRII-732, A Medoxomil Carbonate Prodrug of Islatravir in Healthy Adult Subjects

  Saturday, October 22, 2022
  12:15 PM - 12:45 PM US ET